K Daniel Spiegelman

Affiliations

  • Director at Vtv Therapeutics Inc. (VTVT), 2025-06-12
  • at Kyverna Therapeutics Inc. (KYTX), 2025-06-02
  • at Maze Therapeutics Inc. (MAZE), 2025-01-30
  • Director at Myriad Genetics Inc (MYGN), 2024-06-07
  • at Spruce Biosciences Inc. (SPRB), 2024-05-24
  • Director at Jiya Acquisition Corp. (JYAC), 2020-11-19
  • Evp, Chief Financial Officer at Biomarin Pharmaceutical Inc (BMRN), 2019-06-07
  • Director at Cascadian Therapeutics Inc. (CASC), 2018-03-13
  • Director at Relypsa Inc (RLYP), 2016-09-02
  • at Anthera Pharmaceuticals Inc (ANTH), 2014-06-16
  • Director at Affymax Inc (AFFY), 2012-06-18
  • Director at Omeros Corp (OMER), 2012-06-04
  • Director at Cyclacel Pharmaceuticals Inc. (CYCC), 2012-05-25
  • Officer at Cv Therapeutics Inc (CVTX), 2009-04-09
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ONTY $1.59 10,000 $15,856.00 40,644 2015-03-26 Filing
ONTY $1.63 10,000 $16,271.00 30,644 2015-03-25 Filing
ONTY $1.59 10,000 $15,856.00 40,644 2015-03-26 Filing
ONTY $1.63 10,000 $16,271.00 30,644 2015-03-25 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MYGN $22.05 3,788 $83,525.40 32,917 2024-06-04 Filing
MYGN $22.04 3,788 $83,487.52 36,705 2024-06-03 Filing
MYGN $23.01 8,638 $198,760.38 40,493 2023-06-02 Filing
MYGN $19.25 6,424 $123,672.92 33,980 2022-06-06 Filing
MYGN $30.52 3,139 $95,794.75 23,129 2021-06-17 Filing